Ronald Shapiro

639 total citations
17 papers, 455 citations indexed

About

Ronald Shapiro is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Ronald Shapiro has authored 17 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 7 papers in Pathology and Forensic Medicine and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Ronald Shapiro's work include Lymphoma Diagnosis and Treatment (7 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Advanced Radiotherapy Techniques (5 papers). Ronald Shapiro is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Advanced Radiotherapy Techniques (5 papers). Ronald Shapiro collaborates with scholars based in United States, Canada and China. Ronald Shapiro's co-authors include Peter A.S. Johnstone, R. Bryan Barriger, Jeffrey G. Brabham, David L. Andolino, M. Henderson, Achilles J. Fakiris, Jeffrey A. Forquer, Higinia R. Cárdenes, Peter A.S. Johnstone and Marc S. Mendonca and has published in prestigious journals such as Free Radical Biology and Medicine, International Journal of Radiation Oncology*Biology*Physics and Urology.

In The Last Decade

Ronald Shapiro

17 papers receiving 450 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ronald Shapiro United States 9 328 233 163 69 52 17 455
Jinming Yu China 13 408 1.2× 136 0.6× 400 2.5× 102 1.5× 39 0.8× 33 627
Qiuan Yang China 11 311 0.9× 178 0.8× 109 0.7× 82 1.2× 131 2.5× 23 445
S. Hominal France 9 340 1.0× 109 0.5× 134 0.8× 134 1.9× 29 0.6× 27 422
L Rosen United States 11 268 0.8× 229 1.0× 115 0.7× 27 0.4× 39 0.8× 42 384
J. McAleese United Kingdom 15 282 0.9× 132 0.6× 202 1.2× 95 1.4× 77 1.5× 48 478
Caitlin A. Schonewolf United States 10 209 0.6× 90 0.4× 96 0.6× 72 1.0× 74 1.4× 37 376
Joanne Meng Canada 6 380 1.2× 176 0.8× 166 1.0× 176 2.6× 82 1.6× 7 508
Gyoergy Kovács Germany 8 413 1.3× 285 1.2× 63 0.4× 59 0.9× 102 2.0× 13 570
Regina Bromley Australia 12 248 0.8× 345 1.5× 235 1.4× 29 0.4× 37 0.7× 30 425
Kerstin Siebenlist Germany 11 181 0.6× 201 0.9× 180 1.1× 72 1.0× 64 1.2× 20 389

Countries citing papers authored by Ronald Shapiro

Since Specialization
Citations

This map shows the geographic impact of Ronald Shapiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald Shapiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald Shapiro more than expected).

Fields of papers citing papers by Ronald Shapiro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald Shapiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald Shapiro. The network helps show where Ronald Shapiro may publish in the future.

Co-authorship network of co-authors of Ronald Shapiro

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald Shapiro. A scholar is included among the top collaborators of Ronald Shapiro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald Shapiro. Ronald Shapiro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Liu, Yongmei, Weili Wang, Kevin Shiue, et al.. (2020). Risk factors for symptomatic radiation pneumonitis after stereotactic body radiation therapy (SBRT) in patients with non-small cell lung cancer. Radiotherapy and Oncology. 156. 231–238. 33 indexed citations
2.
Young, Michael A. & Ronald Shapiro. (2019). Percutaneous Lung Lesion Biopsy (PLLB). StatPearls. 1 indexed citations
3.
Mendonca, Marc S., Helen Chin-Sinex, Gabriel W. Rangel, et al.. (2017). DMAPT inhibits NF-κB activity and increases sensitivity of prostate cancer cells to X-rays in vitro and in tumor xenografts in vivo. Free Radical Biology and Medicine. 112. 318–326. 28 indexed citations
4.
Mendonca, Marc S., Helen Chin-Sinex, Gabriel W. Rangel, et al.. (2017). (P001) DMAPT Inhibits NF-KAPPA B Activity and Increases Sensitivity of Prostate Cancer Cells to X-Rays In Vitro and in Tumor Xenografts In Vivo. International Journal of Radiation Oncology*Biology*Physics. 98(2). E16–E16. 1 indexed citations
5.
Dhakal, Sughosh, Ranjana H. Advani, Leslie K. Ballas, et al.. (2016). ACR Appropriateness Criteria® Hodgkin Lymphoma-Favorable Prognosis Stage I and II. American Journal of Clinical Oncology. 39(6). 535–544. 3 indexed citations
6.
Winkfield, Karen M., Ranjana H. Advani, Leslie K. Ballas, et al.. (2016). ACR Appropriateness Criteria® Recurrent Hodgkin Lymphoma.. PubMed. 30(12). 1099–103, 1106. 2 indexed citations
7.
Shapiro, Ronald, et al.. (2016). Irradiated human endothelial progenitor cells induce bystander killing in human non-small cell lung and pancreatic cancer cells. International Journal of Radiation Biology. 92(8). 427–433. 4 indexed citations
8.
Roberts, Kenneth B., Anas Younes, David Hodgson, et al.. (2016). ACR Appropriateness Criteria® Hodgkin Lymphoma—Unfavorable Clinical Stage I and II. American Journal of Clinical Oncology. 39(4). 384–395. 3 indexed citations
9.
Dabaja, Bouthaina S., Ranjana H. Advani, David Hodgson, et al.. (2015). ACR Appropriateness Criteria® Diffuse Large B-Cell Lymphoma. American Journal of Clinical Oncology. 38(6). 610–620. 6 indexed citations
10.
Ha, Chul S., David Hodgson, Ranjana H. Advani, et al.. (2014). ACR Appropriateness Criteria Follow-up of Hodgkin Lymphoma. Journal of the American College of Radiology. 11(11). 1026–1033.e3. 9 indexed citations
11.
Terezakis, Stephanie A., Monika L. Metzger, David Hodgson, et al.. (2014). ACR appropriateness Criteria® pediatric Hodgkin lymphoma. Pediatric Blood & Cancer. 61(7). 1305–1312. 8 indexed citations
12.
Hoppe, Bradford S., David Hodgson, Ranjana H. Advani, et al.. (2013). ACR Appropriateness Criteria: Localized nodal indolent lymphoma.. PubMed. 27(8). 786–94. 4 indexed citations
13.
Shapiro, Ronald & Peter A.S. Johnstone. (2012). Risk of Gleason Grade Inaccuracies in Prostate Cancer Patients Eligible for Active Surveillance. Urology. 80(3). 661–666. 33 indexed citations
14.
Andolino, David L., Jeffrey A. Forquer, M. Henderson, et al.. (2011). Chest Wall Toxicity After Stereotactic Body Radiotherapy for Malignant Lesions of the Lung and Liver. International Journal of Radiation Oncology*Biology*Physics. 80(3). 692–697. 88 indexed citations
15.
Shapiro, Ronald & Andrew L. Chang. (2011). Urgent radiotherapy is effective in the treatment of metastatic medulloblastoma causing symptomatic brainstem edema. Pediatric Blood & Cancer. 57(6). 1077–1080. 8 indexed citations
16.
Chin-Sinex, Helen, Ronald Shapiro, David Gilley, et al.. (2011). Inhibition of NF-κB and DNA double-strand break repair by DMAPT sensitizes non-small-cell lung cancers to X-rays. Free Radical Biology and Medicine. 51(12). 2249–2258. 22 indexed citations
17.
Barriger, R. Bryan, Jeffrey A. Forquer, Jeffrey G. Brabham, et al.. (2010). A Dose–Volume Analysis of Radiation Pneumonitis in Non–Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 82(1). 457–462. 202 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026